Search from over 60,000 research works

Advanced Search

QSOX2 deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction

[thumbnail of Open Access]
Preview
s41467-024-52587-w.pdf - Published Version (2MB) | Preview
Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Maharaj, A. V. orcid id iconORCID: https://orcid.org/0000-0001-8051-3866, Ishida, M., Rybak, A., Elfeky, R., Andrews, A. orcid id iconORCID: https://orcid.org/0000-0003-2390-657X, Joshi, A., Elmslie, F., Joensuu, A. orcid id iconORCID: https://orcid.org/0000-0002-7547-7458, Kantojärvi, K., Jia, R. Y., Perry, J. R. B. orcid id iconORCID: https://orcid.org/0000-0001-6483-3771, O’Toole, E. A. orcid id iconORCID: https://orcid.org/0000-0002-4084-4836, McGuffin, L. J. orcid id iconORCID: https://orcid.org/0000-0003-4501-4767, Hwa, V. orcid id iconORCID: https://orcid.org/0000-0003-0517-9049 and Storr, H. L. orcid id iconORCID: https://orcid.org/0000-0002-9963-1931 (2024) QSOX2 deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction. Nature Communications, 15 (1). 8420. ISSN 2041-1723 doi: 10.1038/s41467-024-52587-w

Abstract/Summary

Postnatal growth failure is often attributed to dysregulated somatotropin action, however marked genetic and phenotypic heterogeneity exist. We report five patients from three families who present with short stature, immune dysfunction, atopic eczema and gastrointestinal pathology associated with recessive variants in QSOX2. QSOX2 encodes a nuclear membrane protein linked to disulphide isomerase and oxidoreductase activity. Loss of QSOX2 disrupts Growth hormone-mediated STAT5B nuclear translocation despite enhanced Growth hormone-induced STAT5B phosphorylation. Moreover, patient-derived dermal fibroblasts demonstrate Growth hormone-induced mitochondriopathy and reduced mitochondrial membrane potential. Located at the nuclear membrane, QSOX2 acts as a gatekeeper for regulating stabilisation and import of phosphorylated-STAT5B. Altogether, QSOX2 deficiency modulates human growth by impairing Growth hormone-STAT5B downstream activities and mitochondrial dynamics, which contribute to multi-system dysfunction. Furthermore, our work suggests that therapeutic recombinant insulin-like growth factor-1 may circumvent the Growth hormone-STAT5B dysregulation induced by pathological QSOX2 variants and potentially alleviate organ specific disease.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/118744
Item Type Article
Refereed Yes
Divisions Interdisciplinary centres and themes > Institute for Cardiovascular and Metabolic Research (ICMR)
Life Sciences > School of Biological Sciences > Biomedical Sciences
Publisher Nature
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar